PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsCommentRevolutionising reproduction: the future of fertility treatment

BioNews

Revolutionising reproduction: the future of fertility treatment

Published 25 March 2019 posted in Comment and appears in BioNews 992

Author

Ana Hallgarten

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.

The Progress Educational Trust (PET) symposium event 'Revolutionising Reproduction: The Future of Fertility Treatment' took place at the Royal College of Physicians of Edinburgh on the 19th March 2019...

The Progress Educational Trust (PET) symposium event 'Revolutionising Reproduction: The Future of Fertility Treatment' took place at the Royal College of Physicians of Edinburgh on 19 March 2019.

The symposium focused on recent changes in reproductive medicine and embryo research, asking where the rapidly moving boundaries in this field are taking us. The symposium was in two parts: 'Creating Eggs and Sperm Outside the Body' and 'From Genome Editing to Womb Transplants'.

The first session was chaired by Professor Scott Nelson of the University of Glasgow, whose introduction highlighted the importance of providing hope for patients who have lost their fertility, as well as praising innovations in fertility treatment that are taking place across Scotland.

The first speaker was Evelyn Telfer, professor of reproductive biology at the University of Edinburgh. She spoke of the problem that women face of being born with a fixed number of immature eggs, of which only 0.1 percent will successfully ovulate and potentially undergo fertilisation.

Her laboratory is revolutionising techniques to mature eggs outside the body using a multistep culture system that supports human egg growth. This work allows further study of human egg development and has potential for clinical applications pending Human Fertilisation and Embryology Authority (HFEA) approval.

Richard Anderson, professor of clinical reproductive science and head of obstetrics and gynaecology at the University of Edinburgh's Centre for Reproductive Health, began his talk by discussing the need for broadening opportunities in fertility preservation. As an alternative to egg freezing, he introduced the concept of freezing ovarian tissue. Not only can this help providing patients with the chance to have genetically related children, it can also restore patients' ability to produce hormones. Recent studies in mice have shown the success of using female germline stem cells from postnatal ovaries, which could be used to restore ovary function in menopausal women or to help women with other fertility issues.

The final talk of the session focused on fertility preservation in males, and was given by Dr Rod Mitchell, research group leader at the University of Edinburgh's Centre for Reproductive Health. Dr Mitchell explained that fertility in men requires the constant production of sperm, and that sperm freezing is not possible for males who have not undergone puberty, such as childhood cancer patients.

The talk centered around Dr Mitchell's research program storing spermatogonial stem cells of boys under the age of 16 who are at high risk of infertility. These tissues could be cultured for sperm generation, or transplanted back into patients to restore fertility in adulthood. This research has been successful in mice models.

Dr Mitchell also discussed the potential for stem cells, created by reprogramming cells from other body tissues, to be encouraged to produce germ cells which could be then transplanted into the testes. He ended his talk with the statement that fertility preservation must encompass us all, and we should not 'leave the boys behind'.

The audience was then invited to ask questions, focusing on applications and development of these fertility techniques. Discussion followed on whether expectations accompanying fertility preservation could be a burden on child patients, with worries about whether adequate counselling is provided. Professor Telfer emphasised that fertility preservation aims to ensure that all options remain open for the patient, rather than committing the patient to a particular course of action. Dr Mitchell added that the counselling available to young cancer patients can be inconsistent, and that every effort should be made to ensure that they receive ongoing support.

There was also great interest in how young transpeople may feel about preserving gametes or gonadal tissues associated with their dysphoric gender. Professor Anderson suggested that this is a growing area that must be improved, and that fertility preservation or treatment for transpeople can involve difficult decisions for people who are already going through challenging times.

The second session of the symposium was chaired by Professor Anderson and continued the theme on the future of fertility. The session discussed applications of germline genome editing in humans and animals, as well as the future of womb transplantation.

The first speaker of the afternoon session was Dr Norah Fogarty, a researcher at the Crick Institute working closely with Dr Kathy Niakan, the first researcher licensed by the HFEA to use the CRISPR/Cas9 genome editing technique on human embryos. Dr Fogarty presented the group's work understanding gene function in the earliest stages of embryo development.

Dr Fogarty and Dr Niakan studied loss of function of OCT4, a gene known to be important in embryogenesis, and compared results in human and mouse embryos. Surprisingly, knockout of the OCT4 gene was found to have a much more significant effect in human embryos, where only embryos in which some cells still carried OCT4 were able to form a blastocyst. Dr Forgarty discussed how these results demonstrated that CRISPR/Cas9 is an essential tool for studying human gene function, as it is not always possible to rely on mouse models.

The second speaker was Bruce Whitelaw, professor of animal biotechnology and deputy director at the University of Edinburgh's Roslin Institute. He discussed the use of selective breeding to select genetically elite animals, and how changes in technology have meant that probability-based algorithms can now be used to select genetic markers for desired characteristics in livestock. He went on to discuss how CRISPR/Cas9 could be used to improve productivity in agriculture, and also protect livestock such as pigs from viruses including Porcine Reproductive and Respiratory Syndrome (PPRS) which costs Europe €1.5 billion annually. Although regulation of this technique in animals could raise many challenges, he concluded that as the 'genie is out of the bottle' we should and must regulate it.

The final speaker of the afternoon symposium was J Richard Smith, a pioneer in fertility-preserving surgery and the clinical lead at Womb Transplant UK. There are 50,000 women in the UK with absolute uterine factor infertility, who currently can only have children through adoption or surrogacy. A uterus transplant could allow these women to carry their own genetically related child.

Smith discussed the history of uterine transplants, and the turning point for the technique in Sweden in 2012, when multiple donations to multiple recipients were successful and led to eight healthy babies being born. Since then, 56 transplants have taken place worldwide leading to 14 live births, and the operation time for live donation has rapidly decreased. Mr Smith concluded his talk by addressing the regulatory barriers that have to be surmounted before the procedure can be trialled in the UK.

The floor was then opened for questions, and there was a great interest in how the public and media reacted to the Crick's research into the OTC4 gene using CRISPR/Cas9. Dr Fogarty said that the team was very encouraged by the positive reception of their research, which reflected the UK's strong history in being at the forefront of scientific innovation.

Finally, a member of the audience inquired about how regulation of genome edited livestock might work in the UK. Professor Whitelaw explained that countries such as Canada and Japan are moving quickly with regulation, compared to EU countries. The latter are bound by a European Union ruling that animals with edited genomes must be subject to the same regulations that apply to genetically modified organisms (as that category was previously understood).

The symposium made for an enlightening afternoon discussing a range of technologies and applications that stand to revolutionise the future of reproduction.


PET is grateful to the Scottish Government for supporting this event.

PET's next public event will be 'Testing Times: How Should We Use Genomic Data in Assisted Reproduction?', taking place in London on Thursday 16 May. See details of the speakers here and register for free here.

Related Articles

PET BioNews
Comment
1 November 2021 • 2 minutes read

FILM: Advances in Assisted Reproduction – What Can We Expect?

by BioNews

This film documents a Progress Educational Trust event about the future of assisted reproduction...

PET BioNews
News
9 August 2019 • 2 minutes read

Commercial service claims to halt the menopause by 20 years

by Dr Rosie Morley

Women could delay the menopause for up to 20 years according to a UK clinic offering the procedure commercially...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
10 May 2019 • 2 minutes read

Record numbers of single women seeking fertility treatments

by Jakki Magowan

Women without male partners are increasingly seeking fertility treatment according to a new report by the Human Fertilisation and Embryology Authority...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
7 May 2019 • 6 minutes read

How should we use genomic data in assisted reproduction?

by Sandy Starr

Advances in genomics are having a growing impact on fertility treatment and assisted reproduction...

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
15 April 2019 • 6 minutes read

Germline in the sand: where should we draw the boundaries for genome editing?

by Jen Willows

Genome editing was the subject up for discussion at the Progress Educational Trust's 'Germline in the Sand' event, held at the Royal College of Physicians of Edinburgh on 19 March 2019. The discussion, which was supported by the Scottish Government sought

PET BioNews
Comment
17 December 2018 • 3 minutes read

Cautious optimism at the first live birth after womb transplant from deceased donor

by Dr Natasha Hammond-Browning

The news broke on the 4 December 2018 that clinicians had achieved a successful pregnancy and live birth following a uterus transplant from a deceased donor...

PET BioNews
News
7 December 2018 • 2 minutes read

First baby born from womb transplant from deceased donor

by Shaoni Bhattacharya

The world's first baby has been born from a uterus transplanted into a woman from a dead donor...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
2 July 2018 • 2 minutes read

'Artificial ovary' for humans passes key milestone

by Shaoni Bhattacharya

Scientists have successfully supported human follicles — the precursors of egg cells — on a bioengineered ovarian 'scaffold' for the first time. The work is an important proof-of-concept, which may pave the way for developing artificial ovaries for

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
8 June 2018 • 2 minutes read

First UK womb transplant to take place this year

by Sarah Pritchard

The charity Womb Transplant UK has announced its intention to carry out the first womb transplant in the UK by the end of 2018, with living as well as deceased donors...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
26 February 2018 • 2 minutes read

First US baby born after uterus transplant

by Dr Sam Sherratt

A woman in Texas has become the first person in the USA to give birth after receiving a uterus transplant...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Getting reliable fertility advice free of commercial interest

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
8 August 2022 • 2 minutes read

FILM: 200 Years of Mendel – From Peas to Personalised Medicine

1 August 2022 • 4 minutes read

Women's Health Strategy plans reflect rising needs of same-sex female couples

25 July 2022 • 4 minutes read

Was the Women's Health Strategy worth the wait?

25 July 2022 • 4 minutes read

Why the UK should extend the 14-day rule to 28 days

25 July 2022 • 5 minutes read

200 Years of Mendel: From Peas to Personalised Medicine

15 August 2022 • 5 minutes read

Same-sex parent should not have been forced to adopt child

15 August 2022 • 2 minutes read

FILM: Editing the Human Genome – Where Are We Now? What Happens Next?

8 August 2022 • 4 minutes read

Citizenship and same-sex parents – about time, Sweden!

8 August 2022 • 2 minutes read

FILM: 200 Years of Mendel – From Peas to Personalised Medicine

1 August 2022 • 4 minutes read

Women's Health Strategy plans reflect rising needs of same-sex female couples

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856